Search
Search for:
Search for:
Find a Pharmacy
Vertice Login
Menu
About Us
About Us
Our Brand
What We Do
Our People
Contact Us
Careers
FAQ
Workers' Comp Solutions
Workers' Comp Solutions
Pharmacy
Ancillary
Clinical Services
Claims Technology
Claims Technology
Request Demo
Data Analytics
Insights
Insights
RxInformer
Worker's Comprehensive
Clinical Minute
Intelligence
Intelligence
Industry Insights Survey
Industry Insights Survey
2025
2024
2023
2022
2021
2020
2019
Blog
Infographics
Advocacy Compliance
What's Happening
What's Happening
Events
Medmonitor
Social Hub
Customer Center
Customer Center
Pharmacy Search
Ask a Pharmacist
Claims Resources
Claims Resources
Mail Order
Patient Resources
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Transforming the workers’ compensation pharmacy and ancillary benefits management
experience
Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
blog
6 Complexities in Workers’ Comp Claims – and How to Address Them
Let’s look at common complexities in workers’ comp claims – and how a combination of technology, data, and people can help address them.
Read More
rxinformer
The Heart of the Matter: Pharmacy Considerations for Cardiovascular Comorbidities
128 million adults in the U.S. are affected by hypertension and cardiovascular diseases.
Read More
INDUSTRY SURVEY
2025 Industry Survey Report
This seventh annual survey report highlights the top challenges and priorities of 500 industry professionals.
Read More
Featured Videos
Jeanette Connelly, PharmD, a clinical pharmacist at Healthesystems, discusses safety and cost concerns associated with physician dispensing practices in workers' compensation.
Physician Dispensing Concerns with Jeanette Connelly, PharmD
Tate Rice, Healthesystems Product Manager (Clinical) discusses clinical and cost concerns associated with Thermal Compression therapy.
Thermal Compression Therapy with Tate Rice, PT, DPT, MBA
Tate Rice, Healthesystems Product Manager (Clinical) discusses clinical and cost concerns associated with Pulsed Electromagnetic Fields (PEMF) therapy.
Pulsed Electromagnetic Fields (PEMF) Therapy with Tate Rice, PT, DPT, MBA
Tate Rice, Healthesystems Product Manager (Clinical), discusses clinical and cost concerns associated with Interferential Current (IFC) therapy.
Interferential Current (IFC) Therapy with Tate Rice, PT, DPT, MBA
Tate Rice, Healthesystems Product Manager (Clinical) discusses clinical and cost concerns associated with H-Wave therapy.
H-Wave Therapy with Tate Rice, PT, DPT, MBA
Britten Featherston, PharmD discusses how comorbidities and biologic changes impact a growing patient population.
Drug Concerns in Older Patients
Kim Blount, BS Pharm addresses how these non-FDA-approved products may not be effective – or safe.
Private-Label Topicals
Jeanette Connelly, PharmD explains how receiving medications directly from a doctor can bypass key pharmacy safeguards.
Physician Dispensing
Tate Rice, PT, DPT, describes how physical medicine is an important component of recovery from a work-related injury.
Importance of Physical Medicine
Tate Rice, PT, DPT, explains the difference between physical and occupational therapies.
Physical vs Occupational Therapy
Tate Rice, PT, DPT, explains why range of motion is an important physical therapy measure.
Range of Motion
Amanda Waltemath, PharmD, MPH clarifies some of the many risks tied to these popular pain medications.
Opioids & Pain Management
Personalize my experience
Make selections below to see articles and information related to your role and interests.
I am a
Select your Role
Select your Role
Business/Claims Executive
Claims Professional
Employer
Medical Professional
Regulatory & Compliance Officer
Risk Manager
I'm interested in
Pick your interests
All Content
Analytics
Ancillary Benefits/Services
Claims Management
Clinical & Medication Management
Employee Safety & Wellness
Innovation & Tech in Comp
Regulatory Policy & Compliance
Work Comp Trends
Clinical Developments
Update on Antibody Testing
Testing for COVID-19 antibodies is not a conclusive test for infection.
Apr 2020
Clinical Developments
FDA Authorizes First COVID-19 Test for At-Home Sample Collection
This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
Apr 2020
Industry Trends
California State Fund Establishes Two New Funds for COVID-19
$25 million each for essential worker and essential business support funds.
Apr 2020
Regulatory Developments
NCCI Explores Economic Impacts of COVID-19 on Workers’ Comp
Information on layoffs, shutdowns, access to care, and more.
Apr 2020
Clinical Developments
FDA Diagnostic Testing Updates
The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Apr 2020
Regulatory Developments
New York Postpones Formulary Deadlines
Providers receive more time in light of system disruptions due to COVID-19
Apr 2020
Regulatory Developments
Louisiana Issues Emergency Prescription Rules
Emergency rules expiring April 13th expanded indefinitely.
Apr 2020
Industry Trends
An Update from Our CEO Daryl Corr
A message from Healthesystems leadership.
Apr 2020
Medmonitor
COVID-19 Updates from the FDA
New developments with diagnostic testing and the use of chloroquine and hydroxychloroquine.
Apr 2020
Regulatory Developments
Kentucky Renews Order Expanding Pharmacist Powers
These provisions expire May 8, 2020, but may be regularly renewed as necessary.
Apr 2020
This Month's Must Read
Sandy Shtab: Regulatory Acceleration in Response to COVID-19
Healthesystems’ AVP of Advocacy & Compliance discusses regulatory action related to COVID-19 with WorkCompWire.
Apr 2020
Industry Trends
Conference Cancellations Across the Country
With mass gatherings discouraged or temporarily outlawed, many conferences have been canceled or converted to digital formats.
Apr 2020
Clinical Insights
Could Convalescent Plasma Treat COVID-19?
The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.
Apr 2020
Legislation & Policy
More States Make COVID-19 Compensable in Workers’ Comp
With frontline workers at risk, states are expanding coverage to healthcare workers, first responders, and other frontline workers.
Apr 2020
Healthe Developments
Silvia Sacalis: 3 Evolving Clinical Trends in Workers’ Comp
Healthesystems’ VP of Clinical Services discusses population trends, non-opioid pain therapies, and comorbidities with WorkCompWire.
Apr 2020
Industry Trends
California Works to Track COVID-19 Claims
The WCIRB is partnering with workers’ comp organizations across the country
Mar 2020
Regulatory Developments
Montana Delays Drug Formulary for Legacy Claims
In response to the COVID-19 pandemic, the state issued a delay in adherence.
Mar 2020
Clinical Developments
FDA Addresses Manufacturing Disruptions
Will disruptions in manufacturing result in drug shortages?
Mar 2020
Clinical Developments
NSAID Use and COVID-19
FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020
Clinical Developments
COVID-19 and Clinical Trials
COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
Mar 2020
Industry Trends
WCIO Updates Injury Description Tables
Cause Code 83 for Pandemic and Nature Code 83 for COVID-19 will impact future reporting for claims impacted by coronavirus.
Mar 2020
COVID-19 Developments
Keep Track of COVID-19 Developments
Healthesystems has created a developments webpage to track updates impacting workers’ comp.
Mar 2020
Medmonitor
FDA Approves Two Migraine Drugs and Two NSAIDs
Anjeso and a new Advil formulation target pain, while Nurtec™ and Vyepti™ target migraines.
Mar 2020
This Month's Must Read
2020 Workers’ Comp Industry Insights Survey
Healthesystems collaborated with Risk & Insurance to survey 669 workers’ comp professionals on top trends and challenges.
Mar 2020
Clinical Insights
JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder
A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.
Mar 2020
Legislation & Policy
Embracing Telehealth in Reaction to COVID-19
Several state workers’ comp programs are relaxing telehealth rules to promote social distancing.
Mar 2020
Healthe Developments
Sandy Shtab Featured in IAIABC Member Spotlight
Healthesystems’ AVP of Advocacy & Compliance discusses industry challenges, special initiatives, and more in a video spotlight.
Mar 2020
Medmonitor
FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury
A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.
Feb 2020
This Month's Must Read
4 Regulatory Trends to Watch Out for in 2020
What will 2020 hold for marijuana acceptance, employee misclassification, formularies, and AI?
Feb 2020
Clinical Insights
WCIRB Publishes Physical Medicine Report
An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.
Feb 2020
🡨
1
2
3
4
5
…
14
15
16
17
18
19
20
21
22
23
🡪
©
2025
Healthesystems
Workers' Comp Property and Casualty PBM
Expires 01/01/2028
chevron-left
chevron-right
info-circle
caret-right
lock
map-marker
magnifier
cross
menu
arrow-right
cross-circle